Cargando…
Regulation of Serum Sodium Levels during Chemotherapy Using Selective Arginine Vasopressin V2-Receptor Antagonist Tolvaptan in a Four-Year-Old Girl with a Suprasellar Germ Cell Tumor
There are limited reports on the use of tolvaptan for syndrome of inappropriate antidiuretic hormone secretion (SIADH) in children. Managing serum sodium levels in SIADH patients during chemotherapy is often difficult because of the need for massive fluid infusions. We report the course of the use o...
Autores principales: | Hiroshima, Shota, Nyuzuki, Hiromi, Sasaki, Sunao, Ogawa, Yohei, Nagasaki, Keisuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070153/ https://www.ncbi.nlm.nih.gov/pubmed/33920088 http://dx.doi.org/10.3390/children8040293 |
Ejemplares similares
-
Re-Evaluation of the Prevalence of Permanent Congenital Hypothyroidism in Niigata, Japan: A Retrospective Study
por: Nagasaki, Keisuke, et al.
Publicado: (2021) -
A Study of Maternal Patients Diagnosed with Inborn Errors of Metabolism Due to Positive Newborn Mass Screening in Their Newborns
por: Onuki, Takanori, et al.
Publicado: (2023) -
Timing of hyponatremia development in patients with salt-wasting-type
21-hydroxylase deficiency
por: Shima, Rohi, et al.
Publicado: (2020) -
Urine Aquaporin-2: A Promising Marker of Response to the Arginine Vasopressin Type-2 Antagonist, Tolvaptan in Patients with Congestive Heart Failure
por: Imamura, Teruhiko, et al.
Publicado: (2016) -
Hyponatremia in Cirrhosis and End-Stage Liver Disease: Treatment with the Vasopressin V(2)-Receptor Antagonist Tolvaptan
por: Gaglio, Paul, et al.
Publicado: (2012)